# Which Therapy for Acute Heart Attacks? (The WEST Study)

> **NCT00121446** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alberta** · enrollment: 300 (—)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** tenecteplase
- **DRUG:** enoxaparin
- **DRUG:** clopidogrel
- **PROCEDURE:** percutaneous coronary intervention

## Key facts

- **NCT ID:** NCT00121446
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2017-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121446, "Which Therapy for Acute Heart Attacks? (The WEST Study)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00121446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*